Targeted drug 'prolongs survival for cervical cancer patients'

The American Cancer Society estimate that there will be 12,360 new cases of invasive cervical cancer diagnosed this year, with 4,020 deaths from the disease. Now, a phase II trial has found that a targeted antitumor drug could prolong the survival of women with cervical cancer.The research team, led by Dr. via Featured Health News from Medical News Today Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1lNq3H1